✦ LIBER ✦

311 PAIN AND PSA RESPONSES IN METASTATIC HORMONE REFRACTORY PROSTATE CANCER TREATED WITH SATRAPLATIN: RESULTS OF THE SPARC PHASE III TRIAL

✍ Scribed by J.A. Witjes; D. Petrylak; O. Sartor; T. Demkow; J.M. Ferrero; J.C. Eymard; S. Falcon; O.B. Karyakine; O. Krieter; C. Sternberg

Book ID: 119617643
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 317 KB
Volume: 6
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(07)60310-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4010 POSTER Satraplatin increases progre

4010 POSTER Satraplatin increases progression-free survival (PFS) and delays pain progression in hormone refractory prostate cancer (HRPC): Results of SPARC, an international phase III trial with 950 patients

✍ C. Sternberg; O. Sartor; D. Petrylak; J.A. Witjes; I. Bodrogi; P. Harper; J.P. D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 67 KB

What is the real impact of bone pain on

What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?

✍ Stéphane Oudard; Eugeniu Banu; Jacques Medioni; Florian Scotte; Adela Banu; Eric 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

A phase 3 randomized controlled trial of

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer

✍ Michael A. Carducci; Fred Saad; Per-Anders Abrahamsson; David P. Dearnaley; Clau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the efficacy and safety of atrasentan (Xinlay), a selective endothelin‐A receptor antagonist, in patients with metastatic hormone‐refractory prostate cancer (HRPC). ## METHODS. This multinational, double‐blind, placebo‐contro

662 THE SURVIVAL BENEFIT OF PRIOR DEFINI

662 THE SURVIVAL BENEFIT OF PRIOR DEFINITIVE LOCAL THERAPY IN MEN WITH ADVANCED/METASTATIC PROSTATE CANCER: RESULTS FROM A PHASE III PROSPECTIVE RANDOMIZED TRIAL

✍ Williams, Michael; Millikan, Randall; Wang, Xuemei; Pettaway, Curtis 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

Gemcitabine plus vinorelbine versus vino

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

✍ Miguel Martín; Amparo Ruiz; Monserrat Muñoz; Ana Balil; Jesús García-Mata; Lourd 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 132 KB

Phase I/II trial evaluating combined rad

Phase I/II trial evaluating combined radiotherapy and in-situ gene therapy with or without hormonal therapy in the treatment of prostate cancer-an interim report on PSA response and biopsy data

✍ B.S Teh; G.E Ayala; W Mai; M.T Vlachaki; J Caillouet; M Davis; M.M Wheeler; T.M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 21 KB